Mikastar 500 Injection is a prescription antibacterial medicine containing Amikacin 500 mg in 2 mL.
Patients searching for Mikastar 500 Injection uses, Amikacin 500mg injection composition, dosage, side effects, precautions and antibiotic information should understand that this is a prescription medicine requiring careful dose selection and monitoring.
For more prescription healthcare products, you may explore the online pharmacy collection at 24x7Pharma. Always confirm that the product matches the medicine prescribed by your healthcare professional.
Buy Mikastar 500 Injection Online
If your doctor has prescribed Mikastar 500 Injection, you can review the product details before purchasing this prescription antibiotic from 24x7Pharma. Mikastar 500 contains Amikacin, an injectable aminoglycoside antibiotic used for selected serious bacterial infections where the treating physician considers it appropriate.
Before ordering Amikacin 500mg Injection, verify the product name, strength, dosage form, pack size and route of administration mentioned on your prescription.
When purchasing prescription medicines online, check the product packaging, batch information, expiry date and composition after delivery. If there is any difference between the received medicine and your prescription, contact the pharmacy or healthcare provider before use.
For additional information about prescription treatment options, visit the 24x7Pharma prescription medicine collection.
What is Mikastar 500 Injection?
Mikastar 500 Injection is a sterile injectable formulation containing Amikacin.
Amikacin is usually selected based on the suspected or confirmed bacterial organism, the severity of infection and the susceptibility of the bacteria to the antibiotic. In many clinical situations, laboratory culture and sensitivity testing may help doctors determine whether Amikacin is an appropriate treatment option.
This medicine does not treat viral infections. Using Amikacin when it is not medically indicated may expose the patient to unnecessary adverse effects and contribute to antibiotic resistance.
Mikastar 500 Injection Composition
Each 2 mL ampoule or vial contains the equivalent of:
- Amikacin: 500 mg
- Dosage form: Sterile injectable solution
- Route: Intramuscular or intravenous use
- Therapeutic class: Aminoglycoside antibiotic
- Pack information shown: 5 × 2 mL
The active ingredient is generally supplied as Amikacin Sulphate equivalent to the labelled Amikacin strength. Always check the actual product label and package insert for complete formulation details, excipients and storage instructions.
Key Highlights of Mikastar 500 Injection
- Contains Amikacin 500 mg in 2 mL.
- Prescription aminoglycoside antibiotic.
- Used for selected serious bacterial infections.
- Intended for IM or IV administration.
- Must be administered by a qualified healthcare professional.
- May require kidney function assessment during treatment.
- May require hearing and balance monitoring in high-risk patients.
How Does Mikastar 500 Injection Work?
Mikastar 500 Injection works through its active ingredient Amikacin. After administration, the medicine reaches the bloodstream and is distributed to tissues where the infection is present.
Amikacin enters susceptible bacterial cells and binds to the 30S subunit of bacterial ribosomes. Ribosomes are responsible for producing proteins that bacteria need for growth, repair and survival.
By interfering with bacterial protein synthesis, Amikacin causes errors in the production of essential proteins. This disrupts bacterial function and eventually leads to the death of susceptible bacteria.
Amikacin is considered bactericidal, meaning that it kills susceptible bacteria rather than simply slowing their multiplication. Its effectiveness depends on the bacterial organism, antibiotic susceptibility, adequate drug exposure and correct administration.
The medicine does not directly reduce fever or pain in the same way as symptomatic medicines. Instead, it works against the underlying susceptible bacterial infection. Improvement in symptoms depends on the infection being correctly diagnosed and the bacteria responding to treatment.
Pharmacological Action
- Enters susceptible bacterial cells.
- Binds to bacterial 30S ribosomal subunits.
- Interferes with accurate protein synthesis.
- Produces abnormal bacterial proteins.
- Disrupts bacterial growth and survival.
- Produces bactericidal antibacterial activity.
Mikastar 500 Injection Uses
Mikastar 500 Injection uses are associated with the treatment of certain serious bacterial infections caused by organisms susceptible to Amikacin. The exact use depends on the diagnosis, bacterial culture results, infection severity and the treating physician’s assessment.
1. Serious Gram-Negative Bacterial Infections
Amikacin is commonly used against selected Gram-negative bacteria responsible for serious infections. These organisms may cause infections in the urinary tract, bloodstream, lungs, abdomen or other body sites.
2. Complicated Urinary Tract Infections
Complicated infections may occur in patients with urinary obstruction, catheter use, kidney abnormalities or other underlying medical conditions.
Since Amikacin is primarily eliminated through the kidneys, kidney function is particularly important when it is used for urinary infections or in patients with impaired renal function.
3. Hospital-Acquired Infections
Hospital-acquired infections require careful assessment because the causative bacteria and their resistance patterns can vary significantly.
4. Serious Respiratory Tract Infections
Amikacin may be used for selected serious bacterial respiratory infections when injectable antibiotic therapy is required. It is not intended for routine viral cough, cold or influenza.
Respiratory infections should be evaluated carefully before antibiotic treatment because not all cough, fever or breathing symptoms are caused by bacteria.
5. Bloodstream Infections
In selected cases, Amikacin may form part of treatment for serious bloodstream infections caused by susceptible organisms. Bloodstream infections can progress rapidly and require urgent medical evaluation, laboratory testing and close monitoring.
6. Bone and Joint Infections
Some serious bone or joint infections may require combination antibiotic treatment. Amikacin may be considered in selected cases depending on the causative bacteria, susceptibility results and specialist recommendations.
7. Intra-Abdominal and Other Systemic Infections
Depending on the bacterial organism and clinical circumstances, Amikacin may be used as part of a treatment regimen for certain serious systemic or intra-abdominal infections.
It should never be used simply because an infection appears severe. The doctor must determine whether the organism is likely to respond to Amikacin and whether the patient can safely receive it.
Benefits of Mikastar 500 Injection
The main benefit of Mikastar 500 Injection is its antibacterial activity against selected susceptible bacteria that may cause serious infections. It provides a systemic antibiotic option when injectable treatment is considered clinically appropriate.
- Acts against susceptible bacterial organisms.
- May be used for serious bacterial infections requiring injectable therapy.
- Interferes with bacterial protein synthesis.
- Provides bactericidal antibacterial action.
- May be used in carefully selected combination antibiotic regimens.
- Can be useful against certain resistant Gram-negative bacteria when susceptibility is confirmed.
- Allows administration through the prescribed IM or IV route.
These benefits do not mean that Amikacin is suitable for every patient or every infection. Treatment success depends on correct diagnosis, bacterial susceptibility, appropriate dose selection, adequate monitoring and completion of the prescribed treatment plan.
How is Mikastar 500 Injection Given?
Mikastar 500 Injection is administered by a qualified healthcare professional through the prescribed intramuscular or intravenous route.
The healthcare professional determines the appropriate administration method based on the patient’s condition, the formulation instructions and the prescribed treatment plan. Intravenous administration may require appropriate dilution and controlled infusion according to professional guidelines.
Patients should not attempt to inject this medicine themselves. Incorrect injection technique, wrong route, improper dilution or incorrect dosage may result in serious complications.
Amikacin should not be mixed with other injectable medicines in the same syringe or infusion solution unless compatibility has been confirmed by a qualified professional.
Mikastar 500 Injection Dosage
The dosage of Mikastar 500 Injection is individualized and must be decided by the treating doctor. There is no single dose suitable for every patient because Amikacin dosing depends on important clinical factors.
The doctor may consider:
- Body weight
- Age
- Type of bacterial infection
- Severity of infection
- Kidney function
- Hydration status
- Other medicines being used
- Previous aminoglycoside exposure
- Laboratory culture and sensitivity results
- Clinical response to treatment
Patients with impaired kidney function may require dose adjustment or a longer interval between doses. Some patients may require therapeutic drug monitoring to reduce the risk of excessive drug exposure.
Do not request or administer an additional dose simply because symptoms have not improved immediately. The doctor should reassess the infection and treatment response.
Why Kidney Function Matters During Amikacin Treatment
Amikacin is eliminated mainly through the kidneys. If kidney function is reduced, the medicine may remain in the body for longer periods, increasing the risk of toxicity.
For this reason, doctors may evaluate serum creatinine, estimated kidney function or other renal parameters before and during treatment. Monitoring may be especially important in elderly patients, dehydrated patients and individuals receiving other medicines that affect the kidneys.
Patients should inform their doctor if they have:
- Chronic kidney disease
- Reduced urine output
- Previous kidney injury
- Kidney stones or urinary obstruction
- Dehydration
- Previous aminoglycoside-related kidney problems
Promptly report reduced urine production, swelling, unusual weakness or other signs of possible kidney problems.
Hearing and Balance Monitoring
Amikacin may affect the auditory or vestibular system in some patients. Ototoxicity can present as hearing loss, ringing in the ears, dizziness, vertigo or difficulty maintaining balance.
The risk may increase with prolonged treatment, high drug exposure, kidney impairment, dehydration or concurrent use of other medicines that can affect hearing.
Inform your healthcare professional immediately if you experience:
- Ringing or buzzing in the ears
- Reduced hearing
- Difficulty understanding speech
- Persistent dizziness
- Vertigo
- Loss of balance
- Unusual sensitivity to sound
Some hearing-related damage may be permanent, so early reporting is important.
Side Effects of Mikastar 500 Injection
Like other aminoglycoside antibiotics, Mikastar 500 Injection may cause side effects. The risk depends on the dose, duration of treatment, kidney function, age, hydration and other medicines being used.
Possible Less Serious Side Effects
- Nausea
- Vomiting
- Headache
- Dizziness
- Fever
- Injection-site discomfort
- Skin rash
- Temporary weakness
Inform your healthcare professional if these symptoms persist or become troublesome.
Serious Side Effects Requiring Medical Attention
- Reduced urine output
- Swelling of the face, feet or ankles
- Hearing loss
- Ringing in the ears
- Severe dizziness or vertigo
- Balance problems
- Severe muscle weakness
- Difficulty breathing
- Severe allergic reaction
- Sudden worsening of general condition
Amikacin is associated with important risks of nephrotoxicity, ototoxicity and neurotoxicity. Patients should not ignore hearing changes, balance problems or reduced urine output during treatment.
Warnings and Precautions
Before receiving Mikastar 500 Injection, inform your doctor about your complete medical history and all medicines you are taking.
- Use only under medical supervision.
- Inform your doctor if you have kidney disease.
- Tell your doctor about hearing loss or tinnitus.
- Inform your doctor about balance or vestibular disorders.
- Tell your doctor if you are dehydrated.
- Inform your doctor about previous aminoglycoside treatment.
- Tell your doctor if you have myasthenia gravis.
- Inform your doctor about neuromuscular disorders.
- Tell your doctor if you are pregnant or breastfeeding.
- Inform your doctor about all medicines that may affect kidney function.
- Do not self-inject this medicine.
- Do not use it for viral infections.
- Attend recommended blood tests and monitoring appointments.
Drug Interactions with Mikastar 500 Injection
Amikacin may interact with medicines that increase the risk of kidney toxicity, hearing toxicity or neuromuscular complications. Provide your healthcare professional with a complete list of all medicines, supplements and herbal products you are taking.
Medicines requiring particular caution may include:
- Other aminoglycoside antibiotics
- Vancomycin
- Colistin
- Polymyxin antibiotics
- Amphotericin B
- Cisplatin
- Loop diuretics such as furosemide
- Some cephalosporin antibiotics
- Neuromuscular blocking agents
- Other nephrotoxic or ototoxic medicines
Do not start, stop or combine medicines without consulting your doctor. Your healthcare provider may adjust treatment or monitoring based on your medication history.
For official prescribing and safety information, healthcare professionals may refer to Amikacin injection labeling information on DailyMed.
Amikacin and Antibiotic Resistance
Antibiotic resistance occurs when bacteria develop the ability to survive medicines that previously killed or inhibited them. Unnecessary antibiotic use, incorrect dosing and incomplete treatment can contribute to resistance.
Mikastar 500 Injection should be used only when prescribed for a suspected or confirmed bacterial infection. It should not be shared with another person or saved for future illness.
Completing the prescribed course is important unless your doctor changes or stops treatment because of side effects, laboratory findings or another medical reason.
Breastfeeding and Mikastar 500 Injection
If you are breastfeeding, inform your doctor before receiving Amikacin. Your healthcare provider will assess the need for treatment and advise you according to your medical condition and the prescribed regimen.
Do not make independent changes to breastfeeding or antibiotic treatment without consulting a healthcare professional.
Use in Elderly Patients
Elderly patients may have reduced kidney function even when they do not experience obvious symptoms. Since Amikacin is cleared through the kidneys, older adults may require careful dose selection and monitoring.
The doctor may review kidney function, hydration status, hearing history and other medicines before and during treatment.
Use in Children
Mikastar 500 Injection should be used in children only when prescribed by a qualified pediatrician or specialist.
Pediatric dosing is based on factors such as body weight, age, infection severity, kidney function and clinical response. Parents should not arrange antibiotic injections for children without medical evaluation.
Alcohol and Lifestyle Considerations
Patients receiving Amikacin should follow the treatment and hydration advice provided by their healthcare professional. If dizziness, weakness or balance problems occur, avoid activities requiring alertness until medical advice is obtained.
Patients should inform their doctor about dehydration, vomiting, diarrhoea or reduced fluid intake because dehydration may increase the risk of kidney-related complications in susceptible individuals.
Storage and Handling Instructions
- Store according to the manufacturer’s instructions on the package.
- Keep away from excessive heat and direct sunlight.
- Do not use after the expiry date.
- Do not use if the container is damaged or the solution appears abnormal.
- Keep out of reach of children.
- Healthcare professionals should follow sterile handling procedures.
- Dispose of used injectable materials according to medical waste guidelines.
When Should You Seek Immediate Medical Help?
Seek urgent medical attention if you experience severe allergic symptoms, difficulty breathing, facial swelling, sudden hearing loss, severe vertigo, fainting, markedly reduced urine output or severe muscle weakness.
Contact your doctor promptly if your infection symptoms worsen, do not improve as expected or return after treatment. Persistent fever or worsening symptoms may require reassessment of the diagnosis or antibiotic sensitivity.
Frequently Asked Questions
1. What is Mikastar 500 Injection used for?
Mikastar 500 Injection is used under medical supervision for certain serious bacterial infections caused by susceptible bacteria.
2. What is the composition of Mikastar 500 Injection?
It contains Amikacin 500 mg in 2 mL, as indicated on the product packaging.
3. What type of antibiotic is Amikacin?
Amikacin is an aminoglycoside antibiotic that interferes with bacterial protein synthesis.
4. Is Mikastar 500 Injection effective against viral infections?
No. Amikacin does not treat viral infections such as common cold or influenza.
5. Is Mikastar 500 Injection given through IV or IM route?
The packaging indicates IM/IV use. The exact route must be selected and administered by a qualified healthcare professional.
6. Can I self-inject Mikastar 500?
No. It should be administered under appropriate professional medical supervision.
7. Does Amikacin affect kidney function?
Yes. Amikacin may cause kidney toxicity, particularly in patients with kidney disease, dehydration or exposure to other nephrotoxic medicines.
8. Can Amikacin affect hearing?
Yes. It may cause hearing loss, ringing in the ears, dizziness or balance problems.
9. Does Mikastar 500 require kidney tests?
Kidney function may need to be assessed before and during treatment, especially in patients at increased risk of toxicity.
10. What should I do if I miss a scheduled dose?
Inform the healthcare team. Do not arrange an extra dose or double dose yourself.
Why Buy Mikastar 500 Injection from 24x7Pharma?
When purchasing prescription antibiotics, checking the exact product name, composition, strength and dosage form is essential. 24x7Pharma provides a platform to explore prescription healthcare products with relevant product information to support informed purchasing decisions.
Before ordering Mikastar 500 Injection, ensure that it matches your doctor’s prescription. Customers should verify the product packaging, expiry date, batch details and medicine information upon receiving the order.
For more prescription medicines and healthcare products, explore the 24x7Pharma online pharmacy.
Medical Disclaimer
Disclaimer: Mikastar 500 Injection is a prescription antibiotic medicine. The information on this page is intended for general educational and product-information purposes only. It should not replace professional medical advice, diagnosis or treatment.
Amikacin may cause serious kidney, hearing and neurological adverse effects in some patients. It must be administered only according to a qualified healthcare professional’s prescription. Do not self-medicate, self-inject, change the dose or discontinue treatment without medical advice.
Always verify the actual product label, composition, strength, packaging and expiry details before use. Product packaging and availability may vary.
